Literature DB >> 22298280

Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease.

Jagadeesh Bayry, Luc Mouthon, Srini V Kaveri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22298280      PMCID： PMC3623090          DOI： 10.3899/jrheum.111123

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  10 in total

1.  Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function.

Authors:  Aharon Kessel; Hana Ammuri; Regina Peri; Elsa R Pavlotzky; Miri Blank; Yehuda Shoenfeld; Elias Toubi
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

2.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".

Authors:  Anne S De Groot; Leonard Moise; Julie A McMurry; Erik Wambre; Laurence Van Overtvelt; Philippe Moingeon; David W Scott; William Martin
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

Review 3.  What is the contents of the magic draft IVIg?

Authors:  Jean-François Seite; Yehuda Shoenfeld; Pierre Youinou; Sophie Hillion
Journal:  Autoimmun Rev       Date:  2008-05-02       Impact factor: 9.754

4.  Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin.

Authors:  Mohan S Maddur; Janakiraman Vani; Pushpa Hegde; Sebastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  J Allergy Clin Immunol       Date:  2011-02-01       Impact factor: 10.793

Review 5.  Intravenous immunoglobulin therapy in rheumatic diseases.

Authors:  Jagadeesh Bayry; Vir Singh Negi; Srini V Kaveri
Journal:  Nat Rev Rheumatol       Date:  2011-05-10       Impact factor: 20.543

Review 6.  FOXP3+ regulatory T cells in the human immune system.

Authors:  Shimon Sakaguchi; Makoto Miyara; Cristina M Costantino; David A Hafler
Journal:  Nat Rev Immunol       Date:  2010-06-18       Impact factor: 53.106

7.  Cytokines and regulatory T cells in rheumatoid arthritis and their relationship with response to corticosteroids.

Authors:  Banesa de Paz; Mercedes Alperi-López; Francisco J Ballina-García; Catuxa Prado; Carmen Gutiérrez; Ana Suárez
Journal:  J Rheumatol       Date:  2010-10-15       Impact factor: 4.666

Review 8.  Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy.

Authors:  Jagadeesh Bayry; Sophie Sibéril; Frédéric Triebel; David F Tough; Srini V Kaveri
Journal:  Drug Discov Today       Date:  2007-06-27       Impact factor: 7.851

9.  Expansion of CD4+CD25+ regulatory T cells by intravenous immunoglobulin: a critical factor in controlling experimental autoimmune encephalomyelitis.

Authors:  Amal Ephrem; Souleima Chamat; Catherine Miquel; Sylvain Fisson; Luc Mouthon; Giuseppina Caligiuri; Sandrine Delignat; Sriramulu Elluru; Jagadeesh Bayry; Sebastien Lacroix-Desmazes; José L Cohen; Benoît L Salomon; Michel D Kazatchkine; Srini V Kaveri; Namita Misra
Journal:  Blood       Date:  2007-10-11       Impact factor: 22.113

10.  T regulatory cells are markedly diminished in diseased salivary glands of patients with primary Sjögren's syndrome.

Authors:  Xiaomei Li; Xiangpei Li; Long Qian; Guosheng Wang; Hong Zhang; Xiaoqiu Wang; Ke Chen; Zhimin Zhai; Qing Li; Yiping Wang; David C H Harris
Journal:  J Rheumatol       Date:  2007-11-15       Impact factor: 4.666
  10 in total
  22 in total

1.  Intravenous immunoglobulin exerts reciprocal regulation of Th1/Th17 cells and regulatory T cells in Guillain-Barré syndrome patients.

Authors:  Mohan S Maddur; Magalie Rabin; Pushpa Hegde; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Jagadeesh Bayry; Srini V Kaveri
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

2.  Protection in antibody- and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs.

Authors:  Benjamin M Fiebiger; Jad Maamary; Andrew Pincetic; Jeffrey V Ravetch
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

3.  Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation.

Authors:  Mohan S Maddur; Jamma Trinath; Magalie Rabin; Francis Bolgert; Moneger Guy; Jean-Michel Vallat; Laurent Magy; Kithiganahalli N Balaji; Srini V Kaveri; Jagadeesh Bayry
Journal:  Cell Mol Immunol       Date:  2014-12-08       Impact factor: 11.530

4.  Intravenous immunoglobulin and immune response.

Authors:  S V Kaveri; M Lecerf; C Saha; M D Kazatchkine; S Lacroix-Desmazes; J Bayry
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 5.  Intravenous immunoglobulin as clinical immune-modulating therapy.

Authors:  Laurent Gilardin; Jagadeesh Bayry; Srini V Kaveri
Journal:  CMAJ       Date:  2015-02-09       Impact factor: 8.262

6.  Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations.

Authors:  Mohan S Maddur; Meenu Sharma; Pushpa Hegde; Sébastien Lacroix-Desmazes; Srini V Kaveri; Jagadeesh Bayry
Journal:  J Clin Immunol       Date:  2012-08-07       Impact factor: 8.317

7.  Patients treated with high-dose intravenous immunoglobulin show selective activation of regulatory T cells.

Authors:  A S W Tjon; T Tha-In; H J Metselaar; R van Gent; L J W van der Laan; Z M A Groothuismink; P A W te Boekhorst; P M van Hagen; J Kwekkeboom
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

8.  Contributions of T lymphocyte abnormalities to therapeutic outcomes in newly diagnosed patients with immune thrombocytopenia.

Authors:  Zhenhua Zhao; Lei Yang; Guohua Yang; Yun Zhuang; Xifeng Qian; Xin Zhou; Dajiang Xiao; Yunfeng Shen
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

Review 9.  Differences in Anti-Inflammatory Actions of Intravenous Immunoglobulin between Mice and Men: More than Meets the Eye.

Authors:  Angela S W Tjon; Rogier van Gent; Teunis B Geijtenbeek; Jaap Kwekkeboom
Journal:  Front Immunol       Date:  2015-04-28       Impact factor: 7.561

Review 10.  Induction of Regulatory T Cells by Intravenous Immunoglobulin: A Bridge between Adaptive and Innate Immunity.

Authors:  Gabriel N Kaufman; Amir H Massoud; Marieme Dembele; Madelaine Yona; Ciriaco A Piccirillo; Bruce D Mazer
Journal:  Front Immunol       Date:  2015-09-11       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.